| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 703750 | Null | 0.000127064839447042 | -0.0083405352 |
| NSC 726373 | Null | 0.000127064839447042 | -0.23224483 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.000177788864158557 | 0.095041175 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.000177788864158557 | 0.31791559 |
| NSC 675004 | Null | 0.000177788864158557 | 0.27811317 |
| NSC 15372 | 4-Hydroxyphenyl-.beta.-naphthylamine | 0.000190877555957481 | 0.118249 |
| NSC 684043 | 1H-Imidazole-4-carboxamide, 5-[[(2-amino-2-carboxyethyl)thio]azo]- | 0.000285499812229898 | 0.50566139 |
| NSC 741237 | Null | 0.000285499812229898 | 0.14678833 |
| NSC 753188 | 4-chloro-N-(4-(3-(4-chloro-3-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide | 0.000285499812229898 | 0.24407204 |
| NSC 763635 | N-(benzo[d]thiazol-2-yl)-2-phenyl-7-(3,4,5-trimethoxyphenyl)pyrazolo[1,5-a]pyrimidine-5-carboxamide | 0.000337797539144495 | -0.058497072 |